NCT02279433 2025-06-24A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bNuvation Bio Inc.Phase 1 Completed46 enrolled
NCT01970540 2020-03-09Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid TumorsPharmaMarPhase 1 Completed122 enrolled 19 charts
NCT02063958 2018-07-30Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine TumorsEsanex Inc.Phase 1 Completed19 enrolled
NCT01508104 2017-08-23Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid TumorsUniversity of CincinnatiPhase 1 Terminated19 enrolled
NCT00753415 2015-03-17A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)Merck Sharp & Dohme LLCPhase 1 Completed37 enrolled 10 charts